Medical Care
Global Circulating Tumor Cells Market Research Report 2024
- Jan 20, 24
- ID: 10091
- Pages: 90
- Figures: 181
- Views: 45
The Circulating Tumor Cells market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Circulating Tumor Cells market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Circulating Tumor Cells companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Menarini-Silicon Biosystems
Qiagen (Adnagen)
Advanced Cell Diagnostics
ApoCell
Epic Sciences
Greiner Bio-one GmbH
Cynvenio
SurExamBio-Tech
Fluxion Biosciences
Ikonisys
Hangzhou Watson Biotech
Biocept
CytoTrack
Guangzhou Wondfo Biotech
Celsee
Clearbridge Biomedics
ANGLE plc
Segment by Type
CTC Enrichment
CTC Detection
CTC Analysis
Segment by Application
Breast Cancer
Prostate Cancer
Colorectal Cancer
Lung Cancer
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Circulating Tumor Cells companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Circulating Tumor Cells companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Menarini-Silicon Biosystems
Qiagen (Adnagen)
Advanced Cell Diagnostics
ApoCell
Epic Sciences
Greiner Bio-one GmbH
Cynvenio
SurExamBio-Tech
Fluxion Biosciences
Ikonisys
Hangzhou Watson Biotech
Biocept
CytoTrack
Guangzhou Wondfo Biotech
Celsee
Clearbridge Biomedics
ANGLE plc
Segment by Type
CTC Enrichment
CTC Detection
CTC Analysis
Segment by Application
Breast Cancer
Prostate Cancer
Colorectal Cancer
Lung Cancer
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Circulating Tumor Cells companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Circulating Tumor Cells Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 CTC Enrichment
1.2.3 CTC Detection
1.2.4 CTC Analysis
1.3 Market by Application
1.3.1 Global Circulating Tumor Cells Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Breast Cancer
1.3.3 Prostate Cancer
1.3.4 Colorectal Cancer
1.3.5 Lung Cancer
1.3.6 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Circulating Tumor Cells Market Perspective (2019-2030)
2.2 Circulating Tumor Cells Growth Trends by Region
2.2.1 Global Circulating Tumor Cells Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Circulating Tumor Cells Historic Market Size by Region (2019-2024)
2.2.3 Circulating Tumor Cells Forecasted Market Size by Region (2025-2030)
2.3 Circulating Tumor Cells Market Dynamics
2.3.1 Circulating Tumor Cells Industry Trends
2.3.2 Circulating Tumor Cells Market Drivers
2.3.3 Circulating Tumor Cells Market Challenges
2.3.4 Circulating Tumor Cells Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Circulating Tumor Cells Players by Revenue
3.1.1 Global Top Circulating Tumor Cells Players by Revenue (2019-2024)
3.1.2 Global Circulating Tumor Cells Revenue Market Share by Players (2019-2024)
3.2 Global Circulating Tumor Cells Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Circulating Tumor Cells Revenue
3.4 Global Circulating Tumor Cells Market Concentration Ratio
3.4.1 Global Circulating Tumor Cells Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Circulating Tumor Cells Revenue in 2023
3.5 Circulating Tumor Cells Key Players Head office and Area Served
3.6 Key Players Circulating Tumor Cells Product Solution and Service
3.7 Date of Enter into Circulating Tumor Cells Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Circulating Tumor Cells Breakdown Data by Type
4.1 Global Circulating Tumor Cells Historic Market Size by Type (2019-2024)
4.2 Global Circulating Tumor Cells Forecasted Market Size by Type (2025-2030)
5 Circulating Tumor Cells Breakdown Data by Application
5.1 Global Circulating Tumor Cells Historic Market Size by Application (2019-2024)
5.2 Global Circulating Tumor Cells Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Circulating Tumor Cells Market Size (2019-2030)
6.2 North America Circulating Tumor Cells Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Circulating Tumor Cells Market Size by Country (2019-2024)
6.4 North America Circulating Tumor Cells Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Circulating Tumor Cells Market Size (2019-2030)
7.2 Europe Circulating Tumor Cells Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Circulating Tumor Cells Market Size by Country (2019-2024)
7.4 Europe Circulating Tumor Cells Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Circulating Tumor Cells Market Size (2019-2030)
8.2 Asia-Pacific Circulating Tumor Cells Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Circulating Tumor Cells Market Size by Region (2019-2024)
8.4 Asia-Pacific Circulating Tumor Cells Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Circulating Tumor Cells Market Size (2019-2030)
9.2 Latin America Circulating Tumor Cells Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Circulating Tumor Cells Market Size by Country (2019-2024)
9.4 Latin America Circulating Tumor Cells Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Circulating Tumor Cells Market Size (2019-2030)
10.2 Middle East & Africa Circulating Tumor Cells Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Circulating Tumor Cells Market Size by Country (2019-2024)
10.4 Middle East & Africa Circulating Tumor Cells Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Menarini-Silicon Biosystems
11.1.1 Menarini-Silicon Biosystems Company Detail
11.1.2 Menarini-Silicon Biosystems Business Overview
11.1.3 Menarini-Silicon Biosystems Circulating Tumor Cells Introduction
11.1.4 Menarini-Silicon Biosystems Revenue in Circulating Tumor Cells Business (2019-2024)
11.1.5 Menarini-Silicon Biosystems Recent Development
11.2 Qiagen (Adnagen)
11.2.1 Qiagen (Adnagen) Company Detail
11.2.2 Qiagen (Adnagen) Business Overview
11.2.3 Qiagen (Adnagen) Circulating Tumor Cells Introduction
11.2.4 Qiagen (Adnagen) Revenue in Circulating Tumor Cells Business (2019-2024)
11.2.5 Qiagen (Adnagen) Recent Development
11.3 Advanced Cell Diagnostics
11.3.1 Advanced Cell Diagnostics Company Detail
11.3.2 Advanced Cell Diagnostics Business Overview
11.3.3 Advanced Cell Diagnostics Circulating Tumor Cells Introduction
11.3.4 Advanced Cell Diagnostics Revenue in Circulating Tumor Cells Business (2019-2024)
11.3.5 Advanced Cell Diagnostics Recent Development
11.4 ApoCell
11.4.1 ApoCell Company Detail
11.4.2 ApoCell Business Overview
11.4.3 ApoCell Circulating Tumor Cells Introduction
11.4.4 ApoCell Revenue in Circulating Tumor Cells Business (2019-2024)
11.4.5 ApoCell Recent Development
11.5 Epic Sciences
11.5.1 Epic Sciences Company Detail
11.5.2 Epic Sciences Business Overview
11.5.3 Epic Sciences Circulating Tumor Cells Introduction
11.5.4 Epic Sciences Revenue in Circulating Tumor Cells Business (2019-2024)
11.5.5 Epic Sciences Recent Development
11.6 Greiner Bio-one GmbH
11.6.1 Greiner Bio-one GmbH Company Detail
11.6.2 Greiner Bio-one GmbH Business Overview
11.6.3 Greiner Bio-one GmbH Circulating Tumor Cells Introduction
11.6.4 Greiner Bio-one GmbH Revenue in Circulating Tumor Cells Business (2019-2024)
11.6.5 Greiner Bio-one GmbH Recent Development
11.7 Cynvenio
11.7.1 Cynvenio Company Detail
11.7.2 Cynvenio Business Overview
11.7.3 Cynvenio Circulating Tumor Cells Introduction
11.7.4 Cynvenio Revenue in Circulating Tumor Cells Business (2019-2024)
11.7.5 Cynvenio Recent Development
11.8 SurExamBio-Tech
11.8.1 SurExamBio-Tech Company Detail
11.8.2 SurExamBio-Tech Business Overview
11.8.3 SurExamBio-Tech Circulating Tumor Cells Introduction
11.8.4 SurExamBio-Tech Revenue in Circulating Tumor Cells Business (2019-2024)
11.8.5 SurExamBio-Tech Recent Development
11.9 Fluxion Biosciences
11.9.1 Fluxion Biosciences Company Detail
11.9.2 Fluxion Biosciences Business Overview
11.9.3 Fluxion Biosciences Circulating Tumor Cells Introduction
11.9.4 Fluxion Biosciences Revenue in Circulating Tumor Cells Business (2019-2024)
11.9.5 Fluxion Biosciences Recent Development
11.10 Ikonisys
11.10.1 Ikonisys Company Detail
11.10.2 Ikonisys Business Overview
11.10.3 Ikonisys Circulating Tumor Cells Introduction
11.10.4 Ikonisys Revenue in Circulating Tumor Cells Business (2019-2024)
11.10.5 Ikonisys Recent Development
11.11 Hangzhou Watson Biotech
11.11.1 Hangzhou Watson Biotech Company Detail
11.11.2 Hangzhou Watson Biotech Business Overview
11.11.3 Hangzhou Watson Biotech Circulating Tumor Cells Introduction
11.11.4 Hangzhou Watson Biotech Revenue in Circulating Tumor Cells Business (2019-2024)
11.11.5 Hangzhou Watson Biotech Recent Development
11.12 Biocept
11.12.1 Biocept Company Detail
11.12.2 Biocept Business Overview
11.12.3 Biocept Circulating Tumor Cells Introduction
11.12.4 Biocept Revenue in Circulating Tumor Cells Business (2019-2024)
11.12.5 Biocept Recent Development
11.13 CytoTrack
11.13.1 CytoTrack Company Detail
11.13.2 CytoTrack Business Overview
11.13.3 CytoTrack Circulating Tumor Cells Introduction
11.13.4 CytoTrack Revenue in Circulating Tumor Cells Business (2019-2024)
11.13.5 CytoTrack Recent Development
11.14 Guangzhou Wondfo Biotech
11.14.1 Guangzhou Wondfo Biotech Company Detail
11.14.2 Guangzhou Wondfo Biotech Business Overview
11.14.3 Guangzhou Wondfo Biotech Circulating Tumor Cells Introduction
11.14.4 Guangzhou Wondfo Biotech Revenue in Circulating Tumor Cells Business (2019-2024)
11.14.5 Guangzhou Wondfo Biotech Recent Development
11.15 Celsee
11.15.1 Celsee Company Detail
11.15.2 Celsee Business Overview
11.15.3 Celsee Circulating Tumor Cells Introduction
11.15.4 Celsee Revenue in Circulating Tumor Cells Business (2019-2024)
11.15.5 Celsee Recent Development
11.16 Clearbridge Biomedics
11.16.1 Clearbridge Biomedics Company Detail
11.16.2 Clearbridge Biomedics Business Overview
11.16.3 Clearbridge Biomedics Circulating Tumor Cells Introduction
11.16.4 Clearbridge Biomedics Revenue in Circulating Tumor Cells Business (2019-2024)
11.16.5 Clearbridge Biomedics Recent Development
11.17 ANGLE plc
11.17.1 ANGLE plc Company Detail
11.17.2 ANGLE plc Business Overview
11.17.3 ANGLE plc Circulating Tumor Cells Introduction
11.17.4 ANGLE plc Revenue in Circulating Tumor Cells Business (2019-2024)
11.17.5 ANGLE plc Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Circulating Tumor Cells Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 CTC Enrichment
1.2.3 CTC Detection
1.2.4 CTC Analysis
1.3 Market by Application
1.3.1 Global Circulating Tumor Cells Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Breast Cancer
1.3.3 Prostate Cancer
1.3.4 Colorectal Cancer
1.3.5 Lung Cancer
1.3.6 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Circulating Tumor Cells Market Perspective (2019-2030)
2.2 Circulating Tumor Cells Growth Trends by Region
2.2.1 Global Circulating Tumor Cells Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Circulating Tumor Cells Historic Market Size by Region (2019-2024)
2.2.3 Circulating Tumor Cells Forecasted Market Size by Region (2025-2030)
2.3 Circulating Tumor Cells Market Dynamics
2.3.1 Circulating Tumor Cells Industry Trends
2.3.2 Circulating Tumor Cells Market Drivers
2.3.3 Circulating Tumor Cells Market Challenges
2.3.4 Circulating Tumor Cells Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Circulating Tumor Cells Players by Revenue
3.1.1 Global Top Circulating Tumor Cells Players by Revenue (2019-2024)
3.1.2 Global Circulating Tumor Cells Revenue Market Share by Players (2019-2024)
3.2 Global Circulating Tumor Cells Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Circulating Tumor Cells Revenue
3.4 Global Circulating Tumor Cells Market Concentration Ratio
3.4.1 Global Circulating Tumor Cells Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Circulating Tumor Cells Revenue in 2023
3.5 Circulating Tumor Cells Key Players Head office and Area Served
3.6 Key Players Circulating Tumor Cells Product Solution and Service
3.7 Date of Enter into Circulating Tumor Cells Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Circulating Tumor Cells Breakdown Data by Type
4.1 Global Circulating Tumor Cells Historic Market Size by Type (2019-2024)
4.2 Global Circulating Tumor Cells Forecasted Market Size by Type (2025-2030)
5 Circulating Tumor Cells Breakdown Data by Application
5.1 Global Circulating Tumor Cells Historic Market Size by Application (2019-2024)
5.2 Global Circulating Tumor Cells Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Circulating Tumor Cells Market Size (2019-2030)
6.2 North America Circulating Tumor Cells Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Circulating Tumor Cells Market Size by Country (2019-2024)
6.4 North America Circulating Tumor Cells Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Circulating Tumor Cells Market Size (2019-2030)
7.2 Europe Circulating Tumor Cells Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Circulating Tumor Cells Market Size by Country (2019-2024)
7.4 Europe Circulating Tumor Cells Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Circulating Tumor Cells Market Size (2019-2030)
8.2 Asia-Pacific Circulating Tumor Cells Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Circulating Tumor Cells Market Size by Region (2019-2024)
8.4 Asia-Pacific Circulating Tumor Cells Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Circulating Tumor Cells Market Size (2019-2030)
9.2 Latin America Circulating Tumor Cells Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Circulating Tumor Cells Market Size by Country (2019-2024)
9.4 Latin America Circulating Tumor Cells Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Circulating Tumor Cells Market Size (2019-2030)
10.2 Middle East & Africa Circulating Tumor Cells Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Circulating Tumor Cells Market Size by Country (2019-2024)
10.4 Middle East & Africa Circulating Tumor Cells Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Menarini-Silicon Biosystems
11.1.1 Menarini-Silicon Biosystems Company Detail
11.1.2 Menarini-Silicon Biosystems Business Overview
11.1.3 Menarini-Silicon Biosystems Circulating Tumor Cells Introduction
11.1.4 Menarini-Silicon Biosystems Revenue in Circulating Tumor Cells Business (2019-2024)
11.1.5 Menarini-Silicon Biosystems Recent Development
11.2 Qiagen (Adnagen)
11.2.1 Qiagen (Adnagen) Company Detail
11.2.2 Qiagen (Adnagen) Business Overview
11.2.3 Qiagen (Adnagen) Circulating Tumor Cells Introduction
11.2.4 Qiagen (Adnagen) Revenue in Circulating Tumor Cells Business (2019-2024)
11.2.5 Qiagen (Adnagen) Recent Development
11.3 Advanced Cell Diagnostics
11.3.1 Advanced Cell Diagnostics Company Detail
11.3.2 Advanced Cell Diagnostics Business Overview
11.3.3 Advanced Cell Diagnostics Circulating Tumor Cells Introduction
11.3.4 Advanced Cell Diagnostics Revenue in Circulating Tumor Cells Business (2019-2024)
11.3.5 Advanced Cell Diagnostics Recent Development
11.4 ApoCell
11.4.1 ApoCell Company Detail
11.4.2 ApoCell Business Overview
11.4.3 ApoCell Circulating Tumor Cells Introduction
11.4.4 ApoCell Revenue in Circulating Tumor Cells Business (2019-2024)
11.4.5 ApoCell Recent Development
11.5 Epic Sciences
11.5.1 Epic Sciences Company Detail
11.5.2 Epic Sciences Business Overview
11.5.3 Epic Sciences Circulating Tumor Cells Introduction
11.5.4 Epic Sciences Revenue in Circulating Tumor Cells Business (2019-2024)
11.5.5 Epic Sciences Recent Development
11.6 Greiner Bio-one GmbH
11.6.1 Greiner Bio-one GmbH Company Detail
11.6.2 Greiner Bio-one GmbH Business Overview
11.6.3 Greiner Bio-one GmbH Circulating Tumor Cells Introduction
11.6.4 Greiner Bio-one GmbH Revenue in Circulating Tumor Cells Business (2019-2024)
11.6.5 Greiner Bio-one GmbH Recent Development
11.7 Cynvenio
11.7.1 Cynvenio Company Detail
11.7.2 Cynvenio Business Overview
11.7.3 Cynvenio Circulating Tumor Cells Introduction
11.7.4 Cynvenio Revenue in Circulating Tumor Cells Business (2019-2024)
11.7.5 Cynvenio Recent Development
11.8 SurExamBio-Tech
11.8.1 SurExamBio-Tech Company Detail
11.8.2 SurExamBio-Tech Business Overview
11.8.3 SurExamBio-Tech Circulating Tumor Cells Introduction
11.8.4 SurExamBio-Tech Revenue in Circulating Tumor Cells Business (2019-2024)
11.8.5 SurExamBio-Tech Recent Development
11.9 Fluxion Biosciences
11.9.1 Fluxion Biosciences Company Detail
11.9.2 Fluxion Biosciences Business Overview
11.9.3 Fluxion Biosciences Circulating Tumor Cells Introduction
11.9.4 Fluxion Biosciences Revenue in Circulating Tumor Cells Business (2019-2024)
11.9.5 Fluxion Biosciences Recent Development
11.10 Ikonisys
11.10.1 Ikonisys Company Detail
11.10.2 Ikonisys Business Overview
11.10.3 Ikonisys Circulating Tumor Cells Introduction
11.10.4 Ikonisys Revenue in Circulating Tumor Cells Business (2019-2024)
11.10.5 Ikonisys Recent Development
11.11 Hangzhou Watson Biotech
11.11.1 Hangzhou Watson Biotech Company Detail
11.11.2 Hangzhou Watson Biotech Business Overview
11.11.3 Hangzhou Watson Biotech Circulating Tumor Cells Introduction
11.11.4 Hangzhou Watson Biotech Revenue in Circulating Tumor Cells Business (2019-2024)
11.11.5 Hangzhou Watson Biotech Recent Development
11.12 Biocept
11.12.1 Biocept Company Detail
11.12.2 Biocept Business Overview
11.12.3 Biocept Circulating Tumor Cells Introduction
11.12.4 Biocept Revenue in Circulating Tumor Cells Business (2019-2024)
11.12.5 Biocept Recent Development
11.13 CytoTrack
11.13.1 CytoTrack Company Detail
11.13.2 CytoTrack Business Overview
11.13.3 CytoTrack Circulating Tumor Cells Introduction
11.13.4 CytoTrack Revenue in Circulating Tumor Cells Business (2019-2024)
11.13.5 CytoTrack Recent Development
11.14 Guangzhou Wondfo Biotech
11.14.1 Guangzhou Wondfo Biotech Company Detail
11.14.2 Guangzhou Wondfo Biotech Business Overview
11.14.3 Guangzhou Wondfo Biotech Circulating Tumor Cells Introduction
11.14.4 Guangzhou Wondfo Biotech Revenue in Circulating Tumor Cells Business (2019-2024)
11.14.5 Guangzhou Wondfo Biotech Recent Development
11.15 Celsee
11.15.1 Celsee Company Detail
11.15.2 Celsee Business Overview
11.15.3 Celsee Circulating Tumor Cells Introduction
11.15.4 Celsee Revenue in Circulating Tumor Cells Business (2019-2024)
11.15.5 Celsee Recent Development
11.16 Clearbridge Biomedics
11.16.1 Clearbridge Biomedics Company Detail
11.16.2 Clearbridge Biomedics Business Overview
11.16.3 Clearbridge Biomedics Circulating Tumor Cells Introduction
11.16.4 Clearbridge Biomedics Revenue in Circulating Tumor Cells Business (2019-2024)
11.16.5 Clearbridge Biomedics Recent Development
11.17 ANGLE plc
11.17.1 ANGLE plc Company Detail
11.17.2 ANGLE plc Business Overview
11.17.3 ANGLE plc Circulating Tumor Cells Introduction
11.17.4 ANGLE plc Revenue in Circulating Tumor Cells Business (2019-2024)
11.17.5 ANGLE plc Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of Tables
Table 1. Global Circulating Tumor Cells Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030
Table 2. Key Players of CTC Enrichment
Table 3. Key Players of CTC Detection
Table 4. Key Players of CTC Analysis
Table 5. Global Circulating Tumor Cells Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030
Table 6. Global Circulating Tumor Cells Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 7. Global Circulating Tumor Cells Market Size by Region (2019-2024) & (US$ Million)
Table 8. Global Circulating Tumor Cells Market Share by Region (2019-2024)
Table 9. Global Circulating Tumor Cells Forecasted Market Size by Region (2025-2030) & (US$ Million)
Table 10. Global Circulating Tumor Cells Market Share by Region (2025-2030)
Table 11. Circulating Tumor Cells Market Trends
Table 12. Circulating Tumor Cells Market Drivers
Table 13. Circulating Tumor Cells Market Challenges
Table 14. Circulating Tumor Cells Market Restraints
Table 15. Global Circulating Tumor Cells Revenue by Players (2019-2024) & (US$ Million)
Table 16. Global Circulating Tumor Cells Market Share by Players (2019-2024)
Table 17. Global Top Circulating Tumor Cells Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Circulating Tumor Cells as of 2023)
Table 18. Ranking of Global Top Circulating Tumor Cells Companies by Revenue (US$ Million) in 2023
Table 19. Global 5 Largest Players Market Share by Circulating Tumor Cells Revenue (CR5 and HHI) & (2019-2024)
Table 20. Key Players Headquarters and Area Served
Table 21. Key Players Circulating Tumor Cells Product Solution and Service
Table 22. Date of Enter into Circulating Tumor Cells Market
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Circulating Tumor Cells Market Size by Type (2019-2024) & (US$ Million)
Table 25. Global Circulating Tumor Cells Revenue Market Share by Type (2019-2024)
Table 26. Global Circulating Tumor Cells Forecasted Market Size by Type (2025-2030) & (US$ Million)
Table 27. Global Circulating Tumor Cells Revenue Market Share by Type (2025-2030)
Table 28. Global Circulating Tumor Cells Market Size by Application (2019-2024) & (US$ Million)
Table 29. Global Circulating Tumor Cells Revenue Market Share by Application (2019-2024)
Table 30. Global Circulating Tumor Cells Forecasted Market Size by Application (2025-2030) & (US$ Million)
Table 31. Global Circulating Tumor Cells Revenue Market Share by Application (2025-2030)
Table 32. North America Circulating Tumor Cells Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 33. North America Circulating Tumor Cells Market Size by Country (2019-2024) & (US$ Million)
Table 34. North America Circulating Tumor Cells Market Size by Country (2025-2030) & (US$ Million)
Table 35. Europe Circulating Tumor Cells Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 36. Europe Circulating Tumor Cells Market Size by Country (2019-2024) & (US$ Million)
Table 37. Europe Circulating Tumor Cells Market Size by Country (2025-2030) & (US$ Million)
Table 38. Asia-Pacific Circulating Tumor Cells Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030
Table 39. Asia-Pacific Circulating Tumor Cells Market Size by Region (2019-2024) & (US$ Million)
Table 40. Asia-Pacific Circulating Tumor Cells Market Size by Region (2025-2030) & (US$ Million)
Table 41. Latin America Circulating Tumor Cells Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 42. Latin America Circulating Tumor Cells Market Size by Country (2019-2024) & (US$ Million)
Table 43. Latin America Circulating Tumor Cells Market Size by Country (2025-2030) & (US$ Million)
Table 44. Middle East & Africa Circulating Tumor Cells Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 45. Middle East & Africa Circulating Tumor Cells Market Size by Country (2019-2024) & (US$ Million)
Table 46. Middle East & Africa Circulating Tumor Cells Market Size by Country (2025-2030) & (US$ Million)
Table 47. Menarini-Silicon Biosystems Company Detail
Table 48. Menarini-Silicon Biosystems Business Overview
Table 49. Menarini-Silicon Biosystems Circulating Tumor Cells Product
Table 50. Menarini-Silicon Biosystems Revenue in Circulating Tumor Cells Business (2019-2024) & (US$ Million)
Table 51. Menarini-Silicon Biosystems Recent Development
Table 52. Qiagen (Adnagen) Company Detail
Table 53. Qiagen (Adnagen) Business Overview
Table 54. Qiagen (Adnagen) Circulating Tumor Cells Product
Table 55. Qiagen (Adnagen) Revenue in Circulating Tumor Cells Business (2019-2024) & (US$ Million)
Table 56. Qiagen (Adnagen) Recent Development
Table 57. Advanced Cell Diagnostics Company Detail
Table 58. Advanced Cell Diagnostics Business Overview
Table 59. Advanced Cell Diagnostics Circulating Tumor Cells Product
Table 60. Advanced Cell Diagnostics Revenue in Circulating Tumor Cells Business (2019-2024) & (US$ Million)
Table 61. Advanced Cell Diagnostics Recent Development
Table 62. ApoCell Company Detail
Table 63. ApoCell Business Overview
Table 64. ApoCell Circulating Tumor Cells Product
Table 65. ApoCell Revenue in Circulating Tumor Cells Business (2019-2024) & (US$ Million)
Table 66. ApoCell Recent Development
Table 67. Epic Sciences Company Detail
Table 68. Epic Sciences Business Overview
Table 69. Epic Sciences Circulating Tumor Cells Product
Table 70. Epic Sciences Revenue in Circulating Tumor Cells Business (2019-2024) & (US$ Million)
Table 71. Epic Sciences Recent Development
Table 72. Greiner Bio-one GmbH Company Detail
Table 73. Greiner Bio-one GmbH Business Overview
Table 74. Greiner Bio-one GmbH Circulating Tumor Cells Product
Table 75. Greiner Bio-one GmbH Revenue in Circulating Tumor Cells Business (2019-2024) & (US$ Million)
Table 76. Greiner Bio-one GmbH Recent Development
Table 77. Cynvenio Company Detail
Table 78. Cynvenio Business Overview
Table 79. Cynvenio Circulating Tumor Cells Product
Table 80. Cynvenio Revenue in Circulating Tumor Cells Business (2019-2024) & (US$ Million)
Table 81. Cynvenio Recent Development
Table 82. SurExamBio-Tech Company Detail
Table 83. SurExamBio-Tech Business Overview
Table 84. SurExamBio-Tech Circulating Tumor Cells Product
Table 85. SurExamBio-Tech Revenue in Circulating Tumor Cells Business (2019-2024) & (US$ Million)
Table 86. SurExamBio-Tech Recent Development
Table 87. Fluxion Biosciences Company Detail
Table 88. Fluxion Biosciences Business Overview
Table 89. Fluxion Biosciences Circulating Tumor Cells Product
Table 90. Fluxion Biosciences Revenue in Circulating Tumor Cells Business (2019-2024) & (US$ Million)
Table 91. Fluxion Biosciences Recent Development
Table 92. Ikonisys Company Detail
Table 93. Ikonisys Business Overview
Table 94. Ikonisys Circulating Tumor Cells Product
Table 95. Ikonisys Revenue in Circulating Tumor Cells Business (2019-2024) & (US$ Million)
Table 96. Ikonisys Recent Development
Table 97. Hangzhou Watson Biotech Company Detail
Table 98. Hangzhou Watson Biotech Business Overview
Table 99. Hangzhou Watson Biotech Circulating Tumor Cells Product
Table 100. Hangzhou Watson Biotech Revenue in Circulating Tumor Cells Business (2019-2024) & (US$ Million)
Table 101. Hangzhou Watson Biotech Recent Development
Table 102. Biocept Company Detail
Table 103. Biocept Business Overview
Table 104. Biocept Circulating Tumor Cells Product
Table 105. Biocept Revenue in Circulating Tumor Cells Business (2019-2024) & (US$ Million)
Table 106. Biocept Recent Development
Table 107. CytoTrack Company Detail
Table 108. CytoTrack Business Overview
Table 109. CytoTrack Circulating Tumor Cells Product
Table 110. CytoTrack Revenue in Circulating Tumor Cells Business (2019-2024) & (US$ Million)
Table 111. CytoTrack Recent Development
Table 112. Guangzhou Wondfo Biotech Company Detail
Table 113. Guangzhou Wondfo Biotech Business Overview
Table 114. Guangzhou Wondfo Biotech Circulating Tumor Cells Product
Table 115. Guangzhou Wondfo Biotech Revenue in Circulating Tumor Cells Business (2019-2024) & (US$ Million)
Table 116. Guangzhou Wondfo Biotech Recent Development
Table 117. Celsee Company Detail
Table 118. Celsee Business Overview
Table 119. Celsee Circulating Tumor Cells Product
Table 120. Celsee Revenue in Circulating Tumor Cells Business (2019-2024) & (US$ Million)
Table 121. Celsee Recent Development
Table 122. Clearbridge Biomedics Company Detail
Table 123. Clearbridge Biomedics Business Overview
Table 124. Clearbridge Biomedics Circulating Tumor Cells Product
Table 125. Clearbridge Biomedics Revenue in Circulating Tumor Cells Business (2019-2024) & (US$ Million)
Table 126. Clearbridge Biomedics Recent Development
Table 127. ANGLE plc Company Detail
Table 128. ANGLE plc Business Overview
Table 129. ANGLE plc Circulating Tumor Cells Product
Table 130. ANGLE plc Revenue in Circulating Tumor Cells Business (2019-2024) & (US$ Million)
Table 131. ANGLE plc Recent Development
Table 132. Research Programs/Design for This Report
Table 133. Key Data Information from Secondary Sources
Table 134. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Circulating Tumor Cells Market Size Comparison by Type (2024-2030) & (US$ Million)
Figure 2. Global Circulating Tumor Cells Market Share by Type: 2023 VS 2030
Figure 3. CTC Enrichment Features
Figure 4. CTC Detection Features
Figure 5. CTC Analysis Features
Figure 6. Global Circulating Tumor Cells Market Size Comparison by Application (2024-2030) & (US$ Million)
Figure 7. Global Circulating Tumor Cells Market Share by Application: 2023 VS 2030
Figure 8. Breast Cancer Case Studies
Figure 9. Prostate Cancer Case Studies
Figure 10. Colorectal Cancer Case Studies
Figure 11. Lung Cancer Case Studies
Figure 12. Others Case Studies
Figure 13. Circulating Tumor Cells Report Years Considered
Figure 14. Global Circulating Tumor Cells Market Size (US$ Million), Year-over-Year: 2019-2030
Figure 15. Global Circulating Tumor Cells Market Size, (US$ Million), 2019 VS 2023 VS 2030
Figure 16. Global Circulating Tumor Cells Market Share by Region: 2023 VS 2030
Figure 17. Global Circulating Tumor Cells Market Share by Players in 2023
Figure 18. Global Top Circulating Tumor Cells Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Circulating Tumor Cells as of 2023)
Figure 19. The Top 10 and 5 Players Market Share by Circulating Tumor Cells Revenue in 2023
Figure 20. North America Circulating Tumor Cells Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 21. North America Circulating Tumor Cells Market Share by Country (2019-2030)
Figure 22. United States Circulating Tumor Cells Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 23. Canada Circulating Tumor Cells Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 24. Europe Circulating Tumor Cells Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 25. Europe Circulating Tumor Cells Market Share by Country (2019-2030)
Figure 26. Germany Circulating Tumor Cells Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 27. France Circulating Tumor Cells Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 28. U.K. Circulating Tumor Cells Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 29. Italy Circulating Tumor Cells Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 30. Russia Circulating Tumor Cells Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 31. Nordic Countries Circulating Tumor Cells Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 32. Asia-Pacific Circulating Tumor Cells Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 33. Asia-Pacific Circulating Tumor Cells Market Share by Region (2019-2030)
Figure 34. China Circulating Tumor Cells Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 35. Japan Circulating Tumor Cells Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 36. South Korea Circulating Tumor Cells Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 37. Southeast Asia Circulating Tumor Cells Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 38. India Circulating Tumor Cells Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 39. Australia Circulating Tumor Cells Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 40. Latin America Circulating Tumor Cells Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 41. Latin America Circulating Tumor Cells Market Share by Country (2019-2030)
Figure 42. Mexico Circulating Tumor Cells Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 43. Brazil Circulating Tumor Cells Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 44. Middle East & Africa Circulating Tumor Cells Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 45. Middle East & Africa Circulating Tumor Cells Market Share by Country (2019-2030)
Figure 46. Turkey Circulating Tumor Cells Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 47. Saudi Arabia Circulating Tumor Cells Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 48. Menarini-Silicon Biosystems Revenue Growth Rate in Circulating Tumor Cells Business (2019-2024)
Figure 49. Qiagen (Adnagen) Revenue Growth Rate in Circulating Tumor Cells Business (2019-2024)
Figure 50. Advanced Cell Diagnostics Revenue Growth Rate in Circulating Tumor Cells Business (2019-2024)
Figure 51. ApoCell Revenue Growth Rate in Circulating Tumor Cells Business (2019-2024)
Figure 52. Epic Sciences Revenue Growth Rate in Circulating Tumor Cells Business (2019-2024)
Figure 53. Greiner Bio-one GmbH Revenue Growth Rate in Circulating Tumor Cells Business (2019-2024)
Figure 54. Cynvenio Revenue Growth Rate in Circulating Tumor Cells Business (2019-2024)
Figure 55. SurExamBio-Tech Revenue Growth Rate in Circulating Tumor Cells Business (2019-2024)
Figure 56. Fluxion Biosciences Revenue Growth Rate in Circulating Tumor Cells Business (2019-2024)
Figure 57. Ikonisys Revenue Growth Rate in Circulating Tumor Cells Business (2019-2024)
Figure 58. Hangzhou Watson Biotech Revenue Growth Rate in Circulating Tumor Cells Business (2019-2024)
Figure 59. Biocept Revenue Growth Rate in Circulating Tumor Cells Business (2019-2024)
Figure 60. CytoTrack Revenue Growth Rate in Circulating Tumor Cells Business (2019-2024)
Figure 61. Guangzhou Wondfo Biotech Revenue Growth Rate in Circulating Tumor Cells Business (2019-2024)
Figure 62. Celsee Revenue Growth Rate in Circulating Tumor Cells Business (2019-2024)
Figure 63. Clearbridge Biomedics Revenue Growth Rate in Circulating Tumor Cells Business (2019-2024)
Figure 64. ANGLE plc Revenue Growth Rate in Circulating Tumor Cells Business (2019-2024)
Figure 65. Bottom-up and Top-down Approaches for This Report
Figure 66. Data Triangulation
Figure 67. Key Executives Interviewed
Table 1. Global Circulating Tumor Cells Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030
Table 2. Key Players of CTC Enrichment
Table 3. Key Players of CTC Detection
Table 4. Key Players of CTC Analysis
Table 5. Global Circulating Tumor Cells Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030
Table 6. Global Circulating Tumor Cells Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 7. Global Circulating Tumor Cells Market Size by Region (2019-2024) & (US$ Million)
Table 8. Global Circulating Tumor Cells Market Share by Region (2019-2024)
Table 9. Global Circulating Tumor Cells Forecasted Market Size by Region (2025-2030) & (US$ Million)
Table 10. Global Circulating Tumor Cells Market Share by Region (2025-2030)
Table 11. Circulating Tumor Cells Market Trends
Table 12. Circulating Tumor Cells Market Drivers
Table 13. Circulating Tumor Cells Market Challenges
Table 14. Circulating Tumor Cells Market Restraints
Table 15. Global Circulating Tumor Cells Revenue by Players (2019-2024) & (US$ Million)
Table 16. Global Circulating Tumor Cells Market Share by Players (2019-2024)
Table 17. Global Top Circulating Tumor Cells Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Circulating Tumor Cells as of 2023)
Table 18. Ranking of Global Top Circulating Tumor Cells Companies by Revenue (US$ Million) in 2023
Table 19. Global 5 Largest Players Market Share by Circulating Tumor Cells Revenue (CR5 and HHI) & (2019-2024)
Table 20. Key Players Headquarters and Area Served
Table 21. Key Players Circulating Tumor Cells Product Solution and Service
Table 22. Date of Enter into Circulating Tumor Cells Market
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Circulating Tumor Cells Market Size by Type (2019-2024) & (US$ Million)
Table 25. Global Circulating Tumor Cells Revenue Market Share by Type (2019-2024)
Table 26. Global Circulating Tumor Cells Forecasted Market Size by Type (2025-2030) & (US$ Million)
Table 27. Global Circulating Tumor Cells Revenue Market Share by Type (2025-2030)
Table 28. Global Circulating Tumor Cells Market Size by Application (2019-2024) & (US$ Million)
Table 29. Global Circulating Tumor Cells Revenue Market Share by Application (2019-2024)
Table 30. Global Circulating Tumor Cells Forecasted Market Size by Application (2025-2030) & (US$ Million)
Table 31. Global Circulating Tumor Cells Revenue Market Share by Application (2025-2030)
Table 32. North America Circulating Tumor Cells Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 33. North America Circulating Tumor Cells Market Size by Country (2019-2024) & (US$ Million)
Table 34. North America Circulating Tumor Cells Market Size by Country (2025-2030) & (US$ Million)
Table 35. Europe Circulating Tumor Cells Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 36. Europe Circulating Tumor Cells Market Size by Country (2019-2024) & (US$ Million)
Table 37. Europe Circulating Tumor Cells Market Size by Country (2025-2030) & (US$ Million)
Table 38. Asia-Pacific Circulating Tumor Cells Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030
Table 39. Asia-Pacific Circulating Tumor Cells Market Size by Region (2019-2024) & (US$ Million)
Table 40. Asia-Pacific Circulating Tumor Cells Market Size by Region (2025-2030) & (US$ Million)
Table 41. Latin America Circulating Tumor Cells Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 42. Latin America Circulating Tumor Cells Market Size by Country (2019-2024) & (US$ Million)
Table 43. Latin America Circulating Tumor Cells Market Size by Country (2025-2030) & (US$ Million)
Table 44. Middle East & Africa Circulating Tumor Cells Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 45. Middle East & Africa Circulating Tumor Cells Market Size by Country (2019-2024) & (US$ Million)
Table 46. Middle East & Africa Circulating Tumor Cells Market Size by Country (2025-2030) & (US$ Million)
Table 47. Menarini-Silicon Biosystems Company Detail
Table 48. Menarini-Silicon Biosystems Business Overview
Table 49. Menarini-Silicon Biosystems Circulating Tumor Cells Product
Table 50. Menarini-Silicon Biosystems Revenue in Circulating Tumor Cells Business (2019-2024) & (US$ Million)
Table 51. Menarini-Silicon Biosystems Recent Development
Table 52. Qiagen (Adnagen) Company Detail
Table 53. Qiagen (Adnagen) Business Overview
Table 54. Qiagen (Adnagen) Circulating Tumor Cells Product
Table 55. Qiagen (Adnagen) Revenue in Circulating Tumor Cells Business (2019-2024) & (US$ Million)
Table 56. Qiagen (Adnagen) Recent Development
Table 57. Advanced Cell Diagnostics Company Detail
Table 58. Advanced Cell Diagnostics Business Overview
Table 59. Advanced Cell Diagnostics Circulating Tumor Cells Product
Table 60. Advanced Cell Diagnostics Revenue in Circulating Tumor Cells Business (2019-2024) & (US$ Million)
Table 61. Advanced Cell Diagnostics Recent Development
Table 62. ApoCell Company Detail
Table 63. ApoCell Business Overview
Table 64. ApoCell Circulating Tumor Cells Product
Table 65. ApoCell Revenue in Circulating Tumor Cells Business (2019-2024) & (US$ Million)
Table 66. ApoCell Recent Development
Table 67. Epic Sciences Company Detail
Table 68. Epic Sciences Business Overview
Table 69. Epic Sciences Circulating Tumor Cells Product
Table 70. Epic Sciences Revenue in Circulating Tumor Cells Business (2019-2024) & (US$ Million)
Table 71. Epic Sciences Recent Development
Table 72. Greiner Bio-one GmbH Company Detail
Table 73. Greiner Bio-one GmbH Business Overview
Table 74. Greiner Bio-one GmbH Circulating Tumor Cells Product
Table 75. Greiner Bio-one GmbH Revenue in Circulating Tumor Cells Business (2019-2024) & (US$ Million)
Table 76. Greiner Bio-one GmbH Recent Development
Table 77. Cynvenio Company Detail
Table 78. Cynvenio Business Overview
Table 79. Cynvenio Circulating Tumor Cells Product
Table 80. Cynvenio Revenue in Circulating Tumor Cells Business (2019-2024) & (US$ Million)
Table 81. Cynvenio Recent Development
Table 82. SurExamBio-Tech Company Detail
Table 83. SurExamBio-Tech Business Overview
Table 84. SurExamBio-Tech Circulating Tumor Cells Product
Table 85. SurExamBio-Tech Revenue in Circulating Tumor Cells Business (2019-2024) & (US$ Million)
Table 86. SurExamBio-Tech Recent Development
Table 87. Fluxion Biosciences Company Detail
Table 88. Fluxion Biosciences Business Overview
Table 89. Fluxion Biosciences Circulating Tumor Cells Product
Table 90. Fluxion Biosciences Revenue in Circulating Tumor Cells Business (2019-2024) & (US$ Million)
Table 91. Fluxion Biosciences Recent Development
Table 92. Ikonisys Company Detail
Table 93. Ikonisys Business Overview
Table 94. Ikonisys Circulating Tumor Cells Product
Table 95. Ikonisys Revenue in Circulating Tumor Cells Business (2019-2024) & (US$ Million)
Table 96. Ikonisys Recent Development
Table 97. Hangzhou Watson Biotech Company Detail
Table 98. Hangzhou Watson Biotech Business Overview
Table 99. Hangzhou Watson Biotech Circulating Tumor Cells Product
Table 100. Hangzhou Watson Biotech Revenue in Circulating Tumor Cells Business (2019-2024) & (US$ Million)
Table 101. Hangzhou Watson Biotech Recent Development
Table 102. Biocept Company Detail
Table 103. Biocept Business Overview
Table 104. Biocept Circulating Tumor Cells Product
Table 105. Biocept Revenue in Circulating Tumor Cells Business (2019-2024) & (US$ Million)
Table 106. Biocept Recent Development
Table 107. CytoTrack Company Detail
Table 108. CytoTrack Business Overview
Table 109. CytoTrack Circulating Tumor Cells Product
Table 110. CytoTrack Revenue in Circulating Tumor Cells Business (2019-2024) & (US$ Million)
Table 111. CytoTrack Recent Development
Table 112. Guangzhou Wondfo Biotech Company Detail
Table 113. Guangzhou Wondfo Biotech Business Overview
Table 114. Guangzhou Wondfo Biotech Circulating Tumor Cells Product
Table 115. Guangzhou Wondfo Biotech Revenue in Circulating Tumor Cells Business (2019-2024) & (US$ Million)
Table 116. Guangzhou Wondfo Biotech Recent Development
Table 117. Celsee Company Detail
Table 118. Celsee Business Overview
Table 119. Celsee Circulating Tumor Cells Product
Table 120. Celsee Revenue in Circulating Tumor Cells Business (2019-2024) & (US$ Million)
Table 121. Celsee Recent Development
Table 122. Clearbridge Biomedics Company Detail
Table 123. Clearbridge Biomedics Business Overview
Table 124. Clearbridge Biomedics Circulating Tumor Cells Product
Table 125. Clearbridge Biomedics Revenue in Circulating Tumor Cells Business (2019-2024) & (US$ Million)
Table 126. Clearbridge Biomedics Recent Development
Table 127. ANGLE plc Company Detail
Table 128. ANGLE plc Business Overview
Table 129. ANGLE plc Circulating Tumor Cells Product
Table 130. ANGLE plc Revenue in Circulating Tumor Cells Business (2019-2024) & (US$ Million)
Table 131. ANGLE plc Recent Development
Table 132. Research Programs/Design for This Report
Table 133. Key Data Information from Secondary Sources
Table 134. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Circulating Tumor Cells Market Size Comparison by Type (2024-2030) & (US$ Million)
Figure 2. Global Circulating Tumor Cells Market Share by Type: 2023 VS 2030
Figure 3. CTC Enrichment Features
Figure 4. CTC Detection Features
Figure 5. CTC Analysis Features
Figure 6. Global Circulating Tumor Cells Market Size Comparison by Application (2024-2030) & (US$ Million)
Figure 7. Global Circulating Tumor Cells Market Share by Application: 2023 VS 2030
Figure 8. Breast Cancer Case Studies
Figure 9. Prostate Cancer Case Studies
Figure 10. Colorectal Cancer Case Studies
Figure 11. Lung Cancer Case Studies
Figure 12. Others Case Studies
Figure 13. Circulating Tumor Cells Report Years Considered
Figure 14. Global Circulating Tumor Cells Market Size (US$ Million), Year-over-Year: 2019-2030
Figure 15. Global Circulating Tumor Cells Market Size, (US$ Million), 2019 VS 2023 VS 2030
Figure 16. Global Circulating Tumor Cells Market Share by Region: 2023 VS 2030
Figure 17. Global Circulating Tumor Cells Market Share by Players in 2023
Figure 18. Global Top Circulating Tumor Cells Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Circulating Tumor Cells as of 2023)
Figure 19. The Top 10 and 5 Players Market Share by Circulating Tumor Cells Revenue in 2023
Figure 20. North America Circulating Tumor Cells Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 21. North America Circulating Tumor Cells Market Share by Country (2019-2030)
Figure 22. United States Circulating Tumor Cells Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 23. Canada Circulating Tumor Cells Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 24. Europe Circulating Tumor Cells Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 25. Europe Circulating Tumor Cells Market Share by Country (2019-2030)
Figure 26. Germany Circulating Tumor Cells Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 27. France Circulating Tumor Cells Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 28. U.K. Circulating Tumor Cells Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 29. Italy Circulating Tumor Cells Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 30. Russia Circulating Tumor Cells Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 31. Nordic Countries Circulating Tumor Cells Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 32. Asia-Pacific Circulating Tumor Cells Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 33. Asia-Pacific Circulating Tumor Cells Market Share by Region (2019-2030)
Figure 34. China Circulating Tumor Cells Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 35. Japan Circulating Tumor Cells Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 36. South Korea Circulating Tumor Cells Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 37. Southeast Asia Circulating Tumor Cells Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 38. India Circulating Tumor Cells Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 39. Australia Circulating Tumor Cells Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 40. Latin America Circulating Tumor Cells Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 41. Latin America Circulating Tumor Cells Market Share by Country (2019-2030)
Figure 42. Mexico Circulating Tumor Cells Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 43. Brazil Circulating Tumor Cells Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 44. Middle East & Africa Circulating Tumor Cells Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 45. Middle East & Africa Circulating Tumor Cells Market Share by Country (2019-2030)
Figure 46. Turkey Circulating Tumor Cells Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 47. Saudi Arabia Circulating Tumor Cells Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 48. Menarini-Silicon Biosystems Revenue Growth Rate in Circulating Tumor Cells Business (2019-2024)
Figure 49. Qiagen (Adnagen) Revenue Growth Rate in Circulating Tumor Cells Business (2019-2024)
Figure 50. Advanced Cell Diagnostics Revenue Growth Rate in Circulating Tumor Cells Business (2019-2024)
Figure 51. ApoCell Revenue Growth Rate in Circulating Tumor Cells Business (2019-2024)
Figure 52. Epic Sciences Revenue Growth Rate in Circulating Tumor Cells Business (2019-2024)
Figure 53. Greiner Bio-one GmbH Revenue Growth Rate in Circulating Tumor Cells Business (2019-2024)
Figure 54. Cynvenio Revenue Growth Rate in Circulating Tumor Cells Business (2019-2024)
Figure 55. SurExamBio-Tech Revenue Growth Rate in Circulating Tumor Cells Business (2019-2024)
Figure 56. Fluxion Biosciences Revenue Growth Rate in Circulating Tumor Cells Business (2019-2024)
Figure 57. Ikonisys Revenue Growth Rate in Circulating Tumor Cells Business (2019-2024)
Figure 58. Hangzhou Watson Biotech Revenue Growth Rate in Circulating Tumor Cells Business (2019-2024)
Figure 59. Biocept Revenue Growth Rate in Circulating Tumor Cells Business (2019-2024)
Figure 60. CytoTrack Revenue Growth Rate in Circulating Tumor Cells Business (2019-2024)
Figure 61. Guangzhou Wondfo Biotech Revenue Growth Rate in Circulating Tumor Cells Business (2019-2024)
Figure 62. Celsee Revenue Growth Rate in Circulating Tumor Cells Business (2019-2024)
Figure 63. Clearbridge Biomedics Revenue Growth Rate in Circulating Tumor Cells Business (2019-2024)
Figure 64. ANGLE plc Revenue Growth Rate in Circulating Tumor Cells Business (2019-2024)
Figure 65. Bottom-up and Top-down Approaches for This Report
Figure 66. Data Triangulation
Figure 67. Key Executives Interviewed
Our team would be happy to assist you with your queries.
About us
Accurate data, The latest market trends, And deeper research directions.
Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals
Latest reports
Smart Potentiometric Titrator - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Nov 05, 24
Multifunctional Zeta Potential Analyzer - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Nov 05, 24
Ultrapure Water pH Sensor - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Nov 05, 24
Useful links
Our Contacts
Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China
(+86) 159 1069 5232